Market Overview

DionyMed Fails To Restructure Debt, Heads For Receivership

DionyMed Fails To Restructure Debt, Heads For Receivership

The multistate cannabis brand DionyMed Brands Inc (OTC: DYMEF) said Tuesday it failed to restructure its debt or find a strategic buyer to acquire its assets.

What Happened

DionyMed said Oct. 23 that it would work with lenders on reaching a restructuring solution for its business to continue operating.

On Tuesday, the company said its actions failed to generate any positive results.

The company is in default of $24.81 million plus any additional interest, fees and expenses.

GLAS America, a collateral agent under the company's January credit agreement, served DionyMed with a petition to the Supreme Court of British Columbia to seek the appointment of a receiver over all of the company's properties and assets.

Why It's Important

GLAS already advised the company it will proceed with a receivership application, and the company has no intention of opposing the appointment of a receiver, DionyMed said.

DionyMed's four directors said they will resign upon the appointment of a receiver.

What's Next

The Receivership Petition is scheduled to be heard Oct. 29 in Vancouver.

Related Links:

Educating Investors, Consumers Alike: NorCal's CMO Talks Cannabis Marketing

Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week

Posted-In: Cannabis Markets Best of Benzinga


Related Articles (DYMEF)

View Comments and Join the Discussion!

Cannabis Movers

Sign up for our secret cannabis newsletter!
Never miss out on the breaking news in the Cannabis Industry!